Efavirenz and CYP2B6 polymorphism: Implications for drug toxicity and resistance

Journal article

Open access

Peer reviewed

D. Nolan, E. Phillips and S. Mallal

Clinical Infectious Diseases, Vol.42(3), pp.408-410

2006

Files and links (2)

pdf

efavirenz_and_CYP2B6.pdfDownload View

Published (Version of Record) Open Access

url

Link to Published Version *Subscription may be requiredView

No abstract available

Title: Efavirenz and CYP2B6 polymorphism: Implications for drug toxicity and resistance
Authors/Creators: D. Nolan (Author/Creator) - Royal Perth Hospital
E. Phillips (Author/Creator) - AIDS Vancouver
S. Mallal (Author/Creator) - Royal Perth Hospital
Publication Details: Clinical Infectious Diseases, Vol.42(3), pp.408-410
Publisher: Oxford University Press
Identifiers: 991005540777507891
Copyright: 2005 The Infectious Diseases Society of America
Murdoch Affiliation: Centre for Clinical Immunology and Biomedical Statistics
Language: English
Resource Type: Journal article

This output has contributed to the advancement of the following goals:

Source: InCites

295 File views/ downloads

59 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.66 HIV; 1.66.1372 HIV Comorbidities
Web Of Science research areas: Immunology; Infectious Diseases; Microbiology
ESI research areas: Immunology